The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and their affiliates, ...

In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

The loss of accreditation at the University of Kentucky and University of Illinois testing labs played a role in the ...

A new Federal Trade Commission staff report says major social media and video streaming services conducted vast surveillance ...

The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...

The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.

At its annual sellers’ conference, hosted in Seattle this week, Amazon continually told the thousands of independent vendors ...

FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.

The latest health news covers the European Medicines Agency's approval of Novo Nordisk's Wegovy for heart conditions linked ...

Health-care company stocks fell as U.S. regulators look to crack down on prices and companies battle over market share of popular drugs. The Federal Trade Commission sued the drug middlemen that ...

The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.